URACYL-SPIROOXETAN-NUKLEOSIDE

European patent · EP2430035 · Deleted

Register entry

Publication number
EP2430035
Application number
EP10718207
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
May 11, 2010
Published
Mar 21, 2012
Granted
Apr 3, 2013
Deleted
Dec 24, 2024
Reason
Annual fee unpaid
IPC classes
C07H 19/06 (2006.01)
C07H 19/10 (2006.01)
A61K 31/7072 (2006.01)
Priority
EP 09160215 14.05.2009
PCT application
PCT/EP2010/056438 11.05.2010
PCT publication
WO2010/130726 18.11.2010
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 24, 2024

    Deleted, fee unpaid

    Status of protective title
    Active → Cancelled
    Cancellation date
    24.12.2024
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 24.12.2024

  2. Jun 1, 2023

    Change

    Published in Swissreg on 01.06.2023

  3. Apr 3, 2013

    Granted

    Published in Swissreg on 03.04.2013

Parties

Holder

Janssen Products, L.P.

800/850 Ridgeway Drive, Horsham PA 19044, US

MEDIVIR AB

Medivir AB

Lunastigen 7, 141 44 Huddinge, SE

Inventor

JONCKERS, Tim, Hugo, Maria

B-2650 Edegem, BE

RABOISSON, Pierre, Jean-Marie, Bernard

B-1331 Rosieres, BE

VANDYCK, Koen

B-3583 Paal-Beringen, BE

VAN HOOF, Steven, Maurice, Paula

B-9820 Merelbeke, BE

HU, Lili

B-2800 Mechelen, BE

TAHRI, Abdellah

B-1070 Anderlecht, BE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.